![John Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Kelly
Geschäftsführer bei
PRECISION BIOSCIENCES, INC.
Vermögen: 879 922 $ am 31.07.2026
Profil
John Alexander Kelly is currently Director at California Biomedical Innovation Alliance since 2016 and Chief Operating Officer at Precision BioSciences, Inc. starting in 2026.
Former positions include Director-Investor Relations at Pharmacia & Upjohn, Inc., Executive Director-Investor Relations at Novartis Corp.
from 2003 to 2004, Senior Director-Investor Relations at Pharmacia Corp.
from 2002 to 2003, Director at HealthCare Institute of New Jersey, Treasurer & Director at California Life Sciences Association, Vice President-Investor Relations at Bausch & Lomb, Inc. in 2013, Chief Communications Officer & Senior VP-IR at Forest Laboratories, Inc. from 2013 to 2014, Senior Vice President-Investor Relations at Merck & Co., Inc. from 2004 to 2013, Vice President-Investor Relations at Schering-Plough Corp.
USA, Pharmaceutical Sales Representative at The Upjohn Co., Chief Integration Officer & Senior Vice President at Actavis, Inc. from 2014 to 2015, Chief Communications Officer & Executive VP at Allergan UC from 2015 to 2020, and President at Allergan Foundation.
Education includes undergraduate studies at Purdue University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 125.883 ( 0,52 % ) | 879 922 $ | 31.07.2026 |
Aktive Positionen von John Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Geschäftsführer | 01.08.2026 |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Direktor/Vorstandsmitglied | 02.08.2016 |
Ehemalige bekannte Positionen von John Kelly
| Unternehmen | Position | Ende |
|---|---|---|
| ALLERGAN PLC | Public Communications Contact | 08.05.2020 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Corporate Officer/Principal | 01.05.2015 |
| FOREST LABORATORIES, INC. | Investor Relations Kontakt | 01.07.2014 |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Investor Relations Kontakt | 01.08.2013 |
| MERCK & CO., INC. | Investor Relations Kontakt | 01.05.2013 |
Ausbildung von John Kelly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Health Technology |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Allergan Foundation
 Allergan Foundation Medical/Nursing ServicesHealth Services The Allergan Foundation, operating under AbbVie, provides information and support related to Botox® (onabotulinumtoxinA), a prescription treatment for severe primary axillary hyperhidrosis (severe underarm sweating) in adults when topical medicines are insufficient. The non-profit company is based in Irvine, CA. Botox® is administered by medical professionals and can offer relief for up to approximately seven months. The foundation details the clinical assessment process, important safety information, potential side effects, and the need for patients to disclose medical conditions and medications before treatment. AbbVie also offers patient support programs to assist with medication access and costs. | Health Services |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
